Brooks Laboratories (BOM:533543) E10: ₹-7.75 (As of Mar. 2026)


BOM:533543 Brooks Laboratories Ltd BOM:533543
67 GF Score
Price ₹71.26
GF Value ₹117.95
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Brooks Laboratories E10?

Brooks Laboratories BOM:533543 +3.26% 67 E10 is ₹-7.75 as of Mar. 2026. GuruFocus rates BOM:533543 with a GF Score™ of 67/100 and a GF Value™ of ₹117.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Brooks Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹0.520. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-7.75 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -20.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Brooks Laboratories was -20.00% per year. The lowest was -61.20% per year. And the median was -40.60% per year.

As of today (2026-07-13), Brooks Laboratories's current stock price is ₹71.26. Brooks Laboratories's E10 for the quarter that ended in Mar. 2026 was ₹-7.75. Brooks Laboratories's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Brooks Laboratories was 446.57. The lowest was 27.72. And the median was 59.90.


Brooks Laboratories  (BOM:533543) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Brooks Laboratories was 446.57. The lowest was 27.72. And the median was 59.90.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Brooks Laboratories E10 Related Terms


Brooks Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Brooks Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brooks Laboratories E10 Chart

Brooks Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.77 -4.48 -6.06 -7.41 -7.75

Brooks Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.41 -7.31 -7.30 -7.38 -7.75

BOM:533543 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's Shiller PE Ratio falls into.


BOM:533543
67GF Score
Brooks Laboratories Ltd BOM:533543
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brooks Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Brooks Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.52/164.2724*164.2724
=0.520

Current CPI (Mar. 2026) = 164.2724.

Brooks Laboratories Quarterly Data

per share eps CPI Adj_EPS
201606 0.834 105.961 1.293
201609 0.372 105.961 0.577
201612 0.248 105.196 0.387
201703 -0.603 105.196 -0.942
201706 -2.997 107.109 -4.596
201709 -1.544 109.021 -2.326
201712 -1.338 109.404 -2.009
201803 -1.156 109.786 -1.730
201806 -1.891 111.317 -2.791
201809 -1.024 115.142 -1.461
201812 -1.098 115.142 -1.567
201903 -3.543 118.202 -4.924
201906 -2.288 120.880 -3.109
201909 -0.925 123.175 -1.234
201912 -1.379 126.235 -1.795
202003 -9.569 124.705 -12.605
202006 -1.159 127.000 -1.499
202009 1.337 130.118 1.688
202012 -1.040 130.889 -1.305
202103 -6.170 131.771 -7.692
202106 -0.465 134.084 -0.570
202109 -1.951 135.847 -2.359
202112 -2.654 138.161 -3.156
202203 -2.704 138.822 -3.200
202206 -3.763 142.347 -4.343
202209 -3.190 144.661 -3.622
202212 -2.030 145.763 -2.288
202303 -5.850 146.865 -6.543
202306 -1.810 150.280 -1.979
202309 -0.600 151.492 -0.651
202312 -1.510 152.924 -1.622
202403 -3.770 153.035 -4.047
202406 -0.940 155.789 -0.991
202409 -1.510 157.882 -1.571
202412 -0.820 158.323 -0.851
202503 -0.540 157.552 -0.563
202506 3.250 159.755 3.342
202509 2.710 162.289 2.743
202512 1.870 163.281 1.881
202603 0.520 164.272 0.520

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹-7.75 mean?
Brooks Laboratories (BOM:533543) has a E10 of ₹-7.75 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Brooks Laboratories and its competitors.
Is Brooks Laboratories' E10 too high?
Brooks Laboratories' current E10 is ₹-7.75. Overall, Brooks Laboratories has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Brooks Laboratories' E10 compare to ZTS and UTHR?
Brooks Laboratories' E10 of ₹-7.75 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Brooks Laboratories and its competitors. Brooks Laboratories's current E10 is ₹-7.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brooks Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Brooks Laboratories (BOM:533543) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹117.95, compared to a current price of ₹71.26 — trading 39.6% below its estimated fair value. The current E10 is ₹-7.75. Brooks Laboratories' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Brooks Laboratories (BOM:533543), the current E10 is ₹-7.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Brooks Laboratories (BOM:533543) Overvalued in 2026?

Based on GuruFocus' analysis, Brooks Laboratories stock appears to be undervalued. The current stock price of ₹71.26 is trading 39.6% below its estimated GF Value™ of ₹117.95. GuruFocus considers Brooks Laboratories to be Significantly Undervalued.

Key valuation signals for BOM:533543:

  • E10: ₹-7.75
  • GF Value™: ₹117.95 vs. price of ₹71.26 (39.6% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BOM:533543 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Brooks Laboratories Business Description

Other Exchanges BROOKS:India
Address Near Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is a pharmaceutical manufacturer focused on developing and producing a broad range of generic medicines. Its key segments include injectables, tablets, and dry syrups, with product lines covering antibiotics such as beta-lactams and cephalosporins as well as general critical care injectables. The company operates manufacturing facilities compliant with international quality standards located in India, serving both domestic and international markets. Revenue is generated through contract manufacturing and sales of pharmaceutical formulations distributed broadly across regulated and semi-regulated international markets. The company has obtained regulatory certifications from multiple countries to comply with international standards for pharmaceutical manufacturing.
67GF Score

Get the complete analysis for BOM:533543

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹71.26
Price
₹117.95
GF Value